GoPath Diagnostics, a leading provider of molecular and digital pathology services, today announced the launch of DiabetesNow ...

A new study has found a link between certain midlife vascular risk factors — specifically high blood pressure, diabetes, and ...

This Review briefly outlines the pathophysiology of type 1 diabetes mellitus and discusses therapeutic targets that have reached clinical trials, including immunotherapy, and how these treatments ...

Diabetes is increasing due to obesity and lack of exercise, and if type 2 diabetes patients are accompanied by mental illness ...

Zhejiang University School of Medicine in China, along with American researchers, has found no link between late-life intake ...

In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and b ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

Patients are usually treated by insulin-replacement therapy. This Review briefly outlines the pathophysiology of type 1 diabetes mellitus and discusses therapeutic targets that have reached ...

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the successful de ...

Oct. 2, 2024 — People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low -- from taking too much insulin or not eating enough sugar -- people can ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Obesity caused by a high-fat Western diet damages the pancreas, affecting insulin production and blood sugar control even ...